ArticleAmerican heart journal2020

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial.

Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.